Funded Startups in Jena
Among the 6 most recent funded entries tied to Jena, Thuringen, Germany, InflaRx’s $150M round (2026-05-06) is the only disclosed amount above $50M and dwa…
Among the 6 most recent funded entries tied to Jena, Thuringen, Germany, InflaRx’s $150M round (2026-05-06) is the only disclosed amount above $50M and dwarfs the next-largest disclosed round: rooom’s $18M (2023-09-11). Disclosed amounts cluster into two lower-value points ($7M on 2024-09-25 for Enginsight, plus $18M and $150M), while the remaining listed companies show undisclosed funding amounts.
The list also concentrates in the mid-2022 to 2024 period with a later spike: three rounds fall in 2023–2024 (rooom on 2023-09-11, Oncgnostics on 2023-09-05, and Enginsight on 2024-09-25), and two more appear afterward (DeepEn on 2025-02-17 and InflaRx on 2026-05-06). Sector-wise, Biotechnology appears 3 times (DeepEn, Oncgnostics, InflaRx), while “Series Unknown” appears in 2 rows (InflaRx, Enginsight) and 3 rows are marked “undisclosed” for the amount (DeepEn, Oncgnostics, Coachwhisperer).
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round among these Jena startups, and how does it compare with the other disclosed amounts?
InflaRx’s disclosed $150M round (Series Unknown, 2026-05-06) is the only disclosed amount above $50M. The next-largest disclosed figure is rooom’s $18M (Series A, 2023-09-11), with Enginsight at $7M (Series Unknown, 2024-09-25).
Do multiple companies in this Jena list close funding within a narrow time window?
Yes. Three entries cluster in a short 2023–2024 window: Oncgnostics (2023-09-05, undisclosed), rooom (2023-09-11, $18M), and Enginsight (2024-09-25, $7M). After that, the remaining dated rounds are spaced out: DeepEn (2025-02-17) and InflaRx (2026-05-06).
Are there sector patterns that show up more often than others?
Biotechnology is over-represented in this 6-row sample, appearing 3 times: InflaRx (Health Care, 2026-05-06, $150M), DeepEn (Biotechnology, 2025-02-17, undisclosed), and Oncgnostics (Biotechnology, 2023-09-05, undisclosed). The other sectors each appear once (Hardware: rooom; Information Technology: Enginsight; Commerce and Shopping: Coachwhisperer).
How does the stage mix look across these recent entries?
Seed appears twice (DeepEn is Seed, 2025-02-17; Coachwhisperer is Seed, 2022-05-03) and “Series A” appears once (rooom, 2023-09-11, $18M). “Series Unknown” appears in two rows (InflaRx on 2026-05-06 and Enginsight on 2024-09-25), while the remaining rows have explicit stage labels but undisclosed amounts for DeepEn and Oncgnostics.
Which entries are outliers due to undisclosed amounts or unusually large disclosed funding?
The main disclosed outlier is InflaRx’s $150M (2026-05-06), which sits far above the other disclosed amounts of $18M (rooom, 2023-09-11) and $7M (Enginsight, 2024-09-25). By contrast, three entries list undisclosed amounts: DeepEn (2025-02-17), Oncgnostics (2023-09-05), and Coachwhisperer (2022-05-03).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.